Acumen Pharmaceuticals (ABOS) Current Leases (2022 - 2024)
Acumen Pharmaceuticals (ABOS) posted Current Leases of $129000.0 for Q3 2024, up 3.2% sequentially from $125000.0 in Q2 2024, and up 6350.0% YoY from $2000.0 in Q4 2023.
Acumen Pharmaceuticals (ABOS) Current Leases (2022 - 2024) Analysis & Trends
Acumen Pharmaceuticals has reported Current Leases for 3 years, with the latest figure at $129000.0 in Q3 2024.
- Quarterly Current Leases rose 6350.0% year-over-year to $129000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $129000.0 (up 6350.0% YoY) and the FY2023 annual result came in at $756000.0, up 620.0% from the prior year.
- Current Leases rose to $129000.0 in Q3 2024 per ABOS's latest filing, from $125000.0 in the prior quarter.
- Over five years, Current Leases peaked at $756000.0 in Q4 2023 and troughed at $2000.0 in Q3 2023.
- A 3-year average of $162700.0 and a median of $127000.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases plunged 98.5% in 2023, then surged 6350.0% in 2024.
- Over 3 years, Current Leases stood at $105000.0 in 2022, then soared by 620.0% to $756000.0 in 2023, then plunged by 82.94% to $129000.0 in 2024.
- According to Business Quant data, Current Leases over the past three periods registered $129000.0, $125000.0, and $756000.0 for Q3 2024, Q2 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Acumen Pharmaceuticals | 226.87 Mn | 226.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 125,000.00 |
| Dec 31, 2023 | 756,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 133,000.00 |
| Jun 30, 2022 | 142,000.00 |
| Mar 31, 2022 | 139,000.00 |